Read + Share
Amedeo Smart
Independent Medical Education
Strati P, Champion R, Coleman M, Smith SM, et al. Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study. Br J Haematol 2024 Sep 22. doi: 10.1111/bjh.19787.PMID: 39308028
Email
LinkedIn
Privacy Policy